Clinical Trials Browser

Phase 1/2 × dacetuzumab × Other hematologic neoplasm × Clear all

Hematologic Diseases, Leukemia, Lymphatic Diseases, Lymphoproliferative Disorders, Leukemia, Lymphocytic, Chronic, B-Cell